Sle e p Apne a… T he No t so Sile nt Kille r Dominic A. Munafo, Jr., M.D., F.ABSM Chief Medical Officer
T oday’s Goals Wha t is o b struc tive sle e p a pne a (OSA) Unde rsta nd dia g no sis a nd tre a tme nt Unde rsta nd the b a sic pa tho physio lo g y K no w thre e c o nditio ns hig hly a sso c ia te d with OSA
What is Obstr uc tive Sle e p Apne a (OSA) I nsidio us c o nditio n o f re pe titive pa rtia l o r c o mple te a irwa y c o lla pse during sle e p F re que ntly a ssoc ia te d with: o b e sity • dia b e te s • he a rt dise a se •
T he Obstr uc te d Air way
um o f Dise a se Spe c tr • Sno ring • Uppe r Airwa y Re sista nc e Syndro me - (UARS) • Sle e p Apne a – Ob struc tive – Ce ntra l • Ob e sity Hypo ve ntila tio n Syndro me - (OHS)
Pulmo na ry Dise a se a nd Obe sity Obesity Simple Obesity Obesity Hypoventilation Eucapnic Exercise intolerance Hypercapnic Frequent OSA Dyspnea on exertion Frequent OSA Likely increased Increased post-op risk Abnormal respiratory drive 1. pneumonia respiratory drive 2. atelectasis
Sc ope o f the Pro b le m • 20 - 30 millio n Ame ric a ns • Wisc o nsin sle e p c o ho rt study – 626 sub je c ts a g e 30-60 – AHI > 5 in 9% o f wo me n – AHI > 5 in 24% o f me n Yo ung T , N E ng l J Me d 1993;328
Sc ope o f the Pro b le m • OSA Pr e vale nc e in othe r dise ase state s – Ob e sity – 75% – T ype I I DM – 72% (mo de ra te & se ve re – 66%) – Hype rte nsio n – 50 to 75% – CAD & A. F ib . – 50% – CHF – 50 to 75% – De pre ssio n – 40 to 45%
Obstr uc tive Sle e p Apne a • Most c ommon symptoms – L o ud sno ring – Witne sse d a pne a – E xc e ssive da ytime sle e pine ss – Wa king up c ho king & g a sping – Co g nitive impa irme nt
Obstr uc tive Sle e p Apne a Most c ommon signs • – Ob e sity – Ne c k size ≥ 17 men ≥ 16 women – Na so pha ryng e a l na rro wing – Ma xillo -ma ndib ula r a no ma lie s – Hype rte nsio n – Stro ke – He a rt fa ilure
How to Diagnose Ob struc tive Sle e p Apne a Clinic a l suspic io n • Co nsiste nt sig ns a nd sympto ms • Ove rnig ht sle e p study lo o king • fo r re spira to ry e ve nts (HST o r PSG)
Wha t a re Re spir ator y E ve nts Apne a – no a irflo w ≥ 10 seconds Hypopne a – reduced airflow ≥ 10 se c o nds, usua lly a sso c ia te d with o xyg e n de sa tura tio n o r e vide nc e o f a ro usa l
Diagnosing OSA
Co nse q ue nc e s o f Untre a te d OSA Wo lk, R. e t a l. Circ ula tio n 2003;108:9-12
Co nse q ue nc e s o f Untre a te d OSA L e ung , e t a l. Am J Re spirCrit Ca re Me d 2001;164:2147-65
Co nse q ue nc e s o f Untre a te d OSA 0 - 50 0 150 200 150 Baseline Phenylephrine OSA Calculation of LV transmural pressures 150 - 0 = 150 200 - 0 = 200 150 - (- 50) = 200
Co nse q ue nc e s o f Untre a te d OSA 0 - 50 + 10 150 200 150 Phenylephrine – α 1 agonist CPAP = 10 OSA Calculation of LV transmural pressures 150 - 10 = 140 200 - 0 = 200 150 - (- 50) = 200
E ffe c ts o f the Supine Position • V/ Q misma tc h • Shunting • L ung b a se s we ll pe rfuse d b ut po o rly ve ntila te d • Re duc e d lung vo lume s
E ffe c ts o f the Supine Position Pra c tic a l c o nse q ue nc e • during g e ne ra l a ne sthe sia – Mo re ra pid de c line in o xyg e n sa tura tio n during a pne a , < 2 minute s vs. 6 minute s whe n b re a thing 100% o xyg e n
ity Sc ale o f OSA Se ve r • Apne a Hypopne a Inde x - (AHI) – Mild sle e p a pne a - 5 – 15 e ve nts / ho ur – Mo de ra te sle e p a pne a - 16 – 30 e ve nts / ho ur – Se ve re sle e p a pne a - > 30 e ve nts / ho ur • Who to T re a t ? – AHI ≥ 30 5 - 29 ⇒ if sympto ma tic o r if c o -mo rb iditie s pre se nt – AHI
Co nse q ue nc e s o f Untre a te d OSA OSA is assoc iate d with: No c turna l b lo o d pre ssure e le va tio n • • I nde pe nde nt risk fa c to r fo r hype rte nsio n Cha ng e s in L V g e o me try a nd func tio n • Me ta b o lic Syndro me •
Ultima te Conse que nc e s I nc re a sing pre va le nc e o f c hildho o d o b e sity a nd it’ s c o mplic a tio ns c o uld a c tua lly re sult in the c urre nt g e ne ra tio ns o f c hildre n living le ss we ll and fo r a time tha n pre vio us g e ne ra tio ns sho r te r * Da nie ls, F uture Child. 2006 Spring ;16(1):47-67
e atme nt Options fo r OSA T r • Pe rma ne nt we ig ht lo ss • Co ntinuo us po sitive a irwa y pre ssure (CPAP) • Ora l a pplia nc e s • Ora l a nd/ o r ma xillo -fa c ia l surg e rie s • T ra c he o sto my
CPAP T he r apy for OSA Applie d via na sa l ma sk • Ac ts a s pne uma tic splint • Co mplia nc e limits utility • Ma sk fit c ruc ia l •
T ha nk Yo u! L e ar n Mo r e and Visit Us at Sle e pData.c o m
9/28/2016 Creating Program Elements to Improve the Care of the Dementia is
Practical Advice for All Teachers Supporting Students with Learning
Stroke Recovery Association of BC AGM WELCOME! COORDINATORS SESSION O C T O
Clinical Aspects of ALS Adam Quick, MD Clinical Assistant Professor of
Department of Communication Sciences and Disorders Applying to the M.S.
What do speech pathologists do? Leanne Stein, M.S., CCC-SLP
Sleep Apnea and Congestive Heart Failure, Diagnosis and Management Rami
Oral Appliances- The use of advanced technology for cost effectiveness and
Obstructive sleep apnea and its effects on the Heart! Khizer Shaikh
CLINICAL INDICATORS FOR SLEEP DISORDERED BREATHING AND OBSTRUCTIVE SLEEP
Sleep Apnea Research Jon H. Lemke, Ph.D. Chief Biostatistician Jordan
For personal use only Investor Presentation FY2019 DISCLAIMER &